Halozyme(DE:RV7)
€86.74-3.50 (-3.88%)
DE:RV7
Halozyme earnings date
€86.74
At close:-3.50 (-3.88%)
Halozyme (RV7) Q2 2026 Earnings Report
7 Followers
DE:RV7 Q2 2026 EPS Results
- Actual EPS
- EUR 2.04
- Consensus EPS
- EUR 1.60
- Beat/Miss
- Beat by +EUR 0.44
- One Year Ago EPS
- EUR 1.38
DE:RV7 Q2 2026 Revenue Results
- Actual Revenue
- EUR 430.66M
- Expected Revenue
- EUR 360.18M
- Beat/Miss
- Beat by +EUR 70.48M
- YoY Revenue Growth
- +47.67%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- After Close
- Conference Call
- Thursday, August 6, 2026
DE:RV7 Upcoming Earnings
Halozyme's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:RV7 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RV7 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2026 (Q4) | 2.30- | -0.21 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 2.062.14 | 1.54 | 38.95% (+0.60) | |
| Aug 06, 2026 | 2026 (Q2) | 1.602.04 | 1.38 | 48.05% (+0.66) | |
| May 11, 2026 | 2026 (Q1) | 1.381.43 | 0.99 | 44.14% (+0.44) | |
| Feb 17, 2026 | 2025 (Q4) | 1.97-0.21 | 1.13 | -119.05% (-1.34) | |
| Nov 03, 2025 | 2025 (Q3) | 1.461.54 | 1.14 | 35.43% (+0.40) | |
| Aug 05, 2025 | 2025 (Q2) | 1.141.38 | 0.81 | 69.23% (+0.56) | |
| May 06, 2025 | 2025 (Q1) | 0.850.99 | 0.71 | 40.51% (+0.29) | |
| Feb 18, 2025 | 2024 (Q4) | 1.041.13 | 0.73 | 53.66% (+0.39) | |
| Oct 31, 2024 | 2024 (Q3) | 0.891.14 | 0.67 | 69.33% (+0.47) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


